Success Metrics

Clinical Success Rate
96.0%

Based on 262 completed trials

Completion Rate
96%(262/273)
Active Trials
11(4%)
Results Posted
26%(67 trials)
Terminated
11(4%)

Phase Distribution

Ph phase_3
26
8%
Ph not_applicable
12
4%
Ph phase_4
17
6%
Ph phase_1
216
71%
Ph phase_2
32
10%

Phase Distribution

216

Early Stage

32

Mid Stage

43

Late Stage

Phase Distribution303 total trials
Phase 1Safety & dosage
216(71.3%)
Phase 2Efficacy & side effects
32(10.6%)
Phase 3Large-scale testing
26(8.6%)
Phase 4Post-market surveillance
17(5.6%)
N/ANon-phased studies
12(4.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

94.2%

262 of 278 finished

Non-Completion Rate

5.8%

16 ended early

Currently Active

11

trials recruiting

Total Trials

306

all time

Status Distribution
Active(17)
Completed(262)
Terminated(16)
Other(11)

Detailed Status

Completed262
Terminated11
unknown10
Not yet recruiting6
Recruiting6
Withdrawn5

Development Timeline

Analytics

Development Status

Total Trials
306
Active
11
Success Rate
96.0%
Most Advanced
Phase 4

Trials by Phase

Phase 1216 (71.3%)
Phase 232 (10.6%)
Phase 326 (8.6%)
Phase 417 (5.6%)
N/A12 (4.0%)

Trials by Status

unknown103%
not_yet_recruiting62%
terminated114%
withdrawn52%
completed26286%
suspended10%
recruiting62%
active_not_recruiting52%

Recent Activity

Clinical Trials (306)

Showing 20 of 306 trialsScroll for more
NCT07513207Phase 1

A Study in Healthy People to Test How Vicadrostat Affects the Heart

Active Not Recruiting
NCT06253715Phase 3

Shortened Regimen for Drug-susceptible TB in Children

Recruiting
NCT06441006Phase 2

Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis

Recruiting
NCT07014735Not Applicable

Effect of Hyperglycaemia and Moxifloxacin on QTc Interval in T2DM

Terminated
NCT07272629Phase 1

A Study to Evaluate the Effect of Single Oral Dose of Balinatunfib on Cardiac Repolarization in Healthy Adult Participants.

Completed
NCT05382312Phase 2

Early Bactericidal Activity, Safety & Tolerability of Oral GSK3036656 in a Dual Combination With Novel and Established Antitubercular Agents, or Standard of Care in Adults With Rifampicin Susceptible Pulmonary Tuberculosis

Completed
NCT07595042Phase 2

A Trial of Stratified Patient-Centered Treatment Regimens for Active TB (SPECTRA-TB)

Not Yet Recruiting
NCT04310930Phase 2

Finding the Optimal Regimen for Mycobacterium Abscessus Treatment

Recruiting
NCT05893862Phase 1

A Study To Evaluate The Effect Of A Supratherapeutic Dose Of Elpipodect (MK-8189) On The QTc Interval In Participants With Schizophrenia (MK-8189-019)

Completed
NCT07305831Phase 1

A Clinical Trial to Evaluate the Effect of Ulonivirine (MK-8507) on Heart Rhythm in Healthy Adults (MK-8507-012)

Completed
NCT07485010Phase 2

Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial

Not Yet Recruiting
NCT07422298Phase 1

A Study to Evaluate the Effect of BMS-986278 on Cardiac Repolarization in Healthy Participants

Recruiting
NCT06200467Phase 1

A Study to Test Whether Multiple Doses of BI 456906 Have an Effect on Cardiac Safety in People With Overweight or Obesity

Completed
NCT07063238Phase 1

A Clinical Study of MK-8527 in Healthy Adult Participants (MK-8527-014)

Completed
NCT07229157Phase 1

Effect of Maridebart Cafraglutide on the Heart's Electrical Activity

Active Not Recruiting
NCT07023029Phase 1

A Study on the Effect of Etavopivat on Heart Rhythm in Healthy Participants

Completed
NCT00042289

Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy

Completed
NCT06107036Phase 1

A Study in Healthy People to Test Whether Different Doses of BI 1015550 Have Potential to Induce Heart Rhythm Abnormalities

Completed
NCT01298336Phase 3

Treatment of Mycobacterium Xenopi Pulmonary Infection

Completed
NCT06846866Phase 1

A Study to Investigate the Safety, Tolerability, and Drug Levels of BMS-986419 (Part 1) and the Effects Multiple Doses of BMS-986419 on Cardiac Repolarization (Part 2) in Healthy Participants

Completed

Drug Details

Intervention Type
DRUG
Total Trials
306